Market Tracker

11/27 1:05pm ET

Enzon Pharmaceuticals Inc (NASDAQ:ENZN)

1.08
Data as of Nov 26
 +0.01 / +0.93%
Today’s Change
0.78
Today|||52-Week Range
1.83
-6.90%
Year-to-Date
No recent news for Enzon Pharmaceuticals Inc.

Today’s Trading

Previous close1.07
Today’s open1.07
Day’s range1.07 - 1.10
Volume119,459
Average volume (3 months)478,857
Market cap$47.7M
Dividend yield--
Data as of 3:59pm ET, 11/26/2014

Growth & Valuation

Earnings growth (last year)--
Earnings growth (this year)-241.48%
Earnings growth (next 5 years)+53.00%
Revenue growth (last year)-19.03%
P/E ratio1.7
Price/Sales1.47
Price/Book9.06

Competitors

 Today’s
change
Today’s
% change
ADHDAlcobra Ltd+0.16+4.62%
ACSTAcasti Pharma Inc-0.02-4.55%
AVEOAveo Pharmaceuticals...-0.00-0.29%
OGXIOncoGenex Pharmaceut...+0.02+0.96%
Data as of 3:59pm ET, 11/26/2014

Financials

Last reporting date--
EPS forecast (this quarter)--
Annual revenue (last year)$34.5M
Annual profit (last year)$18.2M
Net profit margin52.62%

Profile

Sector
Health Technology
Industry
Pharmaceuticals: Major
Chief Executive &
Operating Officer
George W. Hebard
Chief Financial Officer &
Vice President-Finance
Richard L. Feinstein
Corporate headquarters
Piscataway, New Jersey

Forecasts